BULLETIN V2025-3934
RAKOVINA THERAPEUTICS INC. ("RKV")
BULLETIN TYPE: Private Placement-Non-Brokered, Convertible Debentures, Amendment
BULLETIN DATE: December 4, 2025
TSX Venture Tier 2 Company
Further to convertible debentures issued pursuant to a private placement originally accepted by the TSX Venture Exchange (the "Exchange") on June 14, 2023 (the "Original Convertible Debentures"), the Exchange has consented to an amendment of the Original Convertible Debentures (the "Amended Convertible Debentures"). The Company is not receiving any new additional funds.
Original
Convertible Debentures
Maturity Date and Underlying
Warrants Expiry: November 29, 2025
Amended
Convertible Debentures
Maturity Date and Underlying
Warrants Expiry: January 28, 2026
Original
Convertible Debentures
Acceleration Clause: N/A
Amended
Convertible Debentures
Acceleration Clause: N/A
The amount of aggregate principal outstanding is $1,454,000. All other details of the Amended Convertible Debentures remain unchanged from the Original Convertible Debentures.
For further information, please refer to the Company's press releases dated June 30, 2025 and November 28, 2025.
_______________________________________
|
|
